Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors.

The molecular chaperone Hsp90 protects deregulated signaling proteins that are vital for tumor growth and survival. Tumors generally display sensitivity and selectivity toward Hsp90 inhibitors; however, the molecular mechanism underlying this phenotype remains undefined. We report that the mitotic checkpoint kinase Mps1 phosphorylates a conserved threonine residue in the amino-domain ...
of Hsp90. This, in turn, regulates chaperone function by reducing Hsp90 ATPase activity while fostering Hsp90 association with kinase clients, including Mps1. Phosphorylation of Hsp90 is also essential for the mitotic checkpoint because it confers Mps1 stability and activity. We identified Cdc14 as the phosphatase that dephosphorylates Hsp90 and disrupts its interaction with Mps1. This causes Mps1 degradation, thus providing a mechanism for its inactivation. Finally, Hsp90 phosphorylation sensitizes cells to its inhibitors, and elevated Mps1 levels confer renal cell carcinoma selectivity to Hsp90 drugs. Mps1 expression level can potentially serve as a predictive indicator of tumor response to Hsp90 inhibitors.
Mesh Terms:
Amino Acid Sequence, Antineoplastic Agents, Carcinoma, Renal Cell, Cell Cycle Proteins, Enzyme Inhibitors, HSP90 Heat-Shock Proteins, Humans, Kidney Neoplasms, Molecular Sequence Data, Phosphorylation, Protein Binding, Protein Processing, Post-Translational, Protein-Serine-Threonine Kinases, Proteolysis, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins
Cell Rep
Date: Feb. 02, 2016
Download Curated Data For This Publication
196233
Switch View:
  • Interactions 216